Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reduction of Neuroinflammatory Mediators
- Molecular classification
- Cytokine, Chemokine, Transcription factor, Inflammasome component, Lipid mediator
01
Overview
Reduction of neuroinflammatory mediators is a therapeutic strategy aimed at decreasing the levels or activity of molecules that drive inflammation within the central nervous system (CNS). These mediators include cytokines, chemokines, reactive oxygen species (ROS), and other signaling molecules produced primarily by glial cells (microglia and astrocytes) in response to injury, infection, or neurodegenerative processes. Approaches include the use of Specialized Pro-resolving Mediators (SPMs), genetic modulation, and pharmacological inhibition of key inflammatory pathways.
02
Mechanism of action
Inhibition of pro-inflammatory signaling pathways (e.g., TLR4/NFκB, p38 MAPK); promotion of inflammation resolution via SPMs; genetic modulation of inflammatory regulators.
03
Biological functions
InflammationImmune responseCell signalingNeurotransmission modulation
04
Disease associations
Alzheimer's diseaseParkinson's diseaseTraumatic brain injuryNeurodegenerative diseasesInflammatory diseases
05
Safety considerations
Potential for immunosuppressionOff-target effectsBlood-brain barrier penetration challengesVariability in individual responsesLimited clinical translation from preclinical models
06
Interacting drugs
Resolvins (RvD2)
4 more in the full profile.
07
Biomarkers
IL-1βIL-6TNF-αCCL2/MCP-1NF-kBNLRP3Caspase-1
Beyond the preview
Go deeper on Reduction of Neuroinflammatory Mediators.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reduction of Neuroinflammatory Mediators.